Cargando…
Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
The necessity of drug combinations to treat leishmaniasis came to the surface mainly because of the toxicity of current treatments and the emergence of resistant strains. The calpain inhibitor MDL28170 has previously shown anti-Leishmania activity, therefore its use in association with standard drug...
Autores principales: | Branquinha, Marta H., Araújo, Pedro S. S., Oliveira, Simone S. C., Sangenito, Leandro S., Gonçalves, Diego S., Seabra, Sérgio H., d’Avila-Levy, Claudia M., Santos, André L. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878347/ https://www.ncbi.nlm.nih.gov/pubmed/35202224 http://dx.doi.org/10.3390/tropicalmed7020029 |
Ejemplares similares
-
Antileishmanial activity of MDL 28170, a potent calpain inhibitor
por: d’Avila-Levy, Claudia M., et al.
Publicado: (2006) -
The Calpain Inhibitor MDL28170 Induces the Expression of Apoptotic Markers in Leishmania amazonensis Promastigotes
por: Marinho, Fernanda A., et al.
Publicado: (2014) -
MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
por: Ennes-Vidal, Vítor, et al.
Publicado: (2011) -
Calpain inhibitor MDL28170 alleviates cerebral ischemia‑reperfusion injury by suppressing inflammation and autophagy in a rat model of cardiac arrest
por: Wang, Wen-Yan, et al.
Publicado: (2023) -
MDL-28170 Has No Analgesic Effect on CCI Induced Neuropathic Pain in Mice
por: Üçeyler, Nurcan, et al.
Publicado: (2010)